J.P. Morgan analyst Anupam Rama maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) on March 6 and set a price target ...
Morgan Stanley assumed coverage of Ultragenyx (RARE) with an Overweight rating and $64 price target The firm sees continued strong Crysvita ...
Monday, March 3, 2025, Eric Crombez, M.D., Chief Medical Officer, will participate in a fireside chat and host 1x1 meetings. Wednesday, March 12, 2025, Eric Crombez will participate in a fireside ...